… The MI-GENES (Myocardial Infarction Genes) Study researched whether informing patients
of their genomic risk score (GRS) in addition to a conventional risk score (CRS) would affect …

… AD risk reduction through an evidence-based, multidomain precision medicine approach.
We … of personalized risk management within an international network of clinician researchers. …

… In order to provide precision medicine to patients with IBD, we need to be able to better
define patient subsets at different levels risk of developing aggressive disease course and who …

… The ultimate success of PRS in precision medicine … risk profile for each patient. By addressing
these key aspects and enhancing our understanding of PRSs role in precision medicine, …

… The AJCC has increasingly recognized the growing need for more accurate and probabilistic
individualized outcome prediction for precision medicine that would incorporate additional …

… of precision medicine and highlight current research that may soon make precision medicine
more … Novel tools such as polygenic risk scores that combine multiple genetic variants are …

… , reflected by varying risk factors, pathophysiological causes, … , or both, exhibit varying risks
of cardiovascular disease and … ) of phenotypic subtypes in precision medicine for OSA. It also …

… of a genetic risk score and its application to an independent group of individuals demonstrates
the potential application of identified genetic loci for use in a precision medicine approach …

… The application of precision medicine in … of the risk and outcome prediction in schizophrenia.
In this narrative review, we summarized the most important findings in precision medicine in …

… risk estimations (CitationHunter 2016). This potential lack of clarity on risk despite the use of
precision medicine … Doctors need to understand the implications of these scores if they are to …